FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.

Saved in:
Bibliographic Details
Title: FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
Authors: Kim S; Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America. sungeunk@amgen.com, Dubrovska A, Salamone RJ, Walker JR, Grandinetti KB, Bonamy GM, Orth AP, Elliott J, Porta DG, Garcia-Echeverria C, Reddy VA
Source: PloS one [PLoS One] 2013; Vol. 8 (1), pp. e51671. Date of Electronic Publication: 2013 Jan 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0051671